Home » Topics » BioWorld Science

BioWorld Science
RSS

Single-dose hepatitis A vaccine available

June 7, 1996

Oral toxoid vaccine under development by OraVax

June 7, 1996

Commencement of SYNSORB Cd phase I trial expected

June 7, 1996

Patient enrollment initiated for SYNSORB Pk

June 7, 1996

TZA-2209: A pure aromatase inhibitor

June 7, 1996

FDA allows initiation of clinical trials on Autologous Fibrinogen Delivery (AFD) kit

June 7, 1996

Genetics Institute readies factor IX marketing application

June 7, 1996

Cor Therapeutics' NDA for Integrilin faces FDA review

June 7, 1996

Gea claims antiplatelet and fibrinolytic compounds

June 7, 1996

PharmaGenics discloses oligonucleotides

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...